These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32163096)

  • 101. Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review.
    Pichler T; Mumm F; Dehar N; Dickman E; Díez de Los Ríos de la Serna C; Dinkel A; Heinrich K; Hennink M; Parviainen AD; Raske V; Wicki N; Moore AC
    Cancer Med; 2024 Feb; 13(3):e6913. PubMed ID: 38298115
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
    Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
    ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling-a Singaporean experience.
    Chin HL; Lam JCM; Christopher D; Michelle PL; Junrong BY
    Front Oncol; 2023; 13():1182639. PubMed ID: 37860182
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.
    Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P
    Support Care Cancer; 2022 Oct; 30(10):8201-8210. PubMed ID: 35809119
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Precision medicine in women with epilepsy: The challenge, systematic review, and future direction.
    Li Y; Zhang S; Snyder MP; Meador KJ
    Epilepsy Behav; 2021 May; 118():107928. PubMed ID: 33774354
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The Ethics of Delivering Precision Medicine-Pretest Counseling and Somatic Genomic Testing.
    Borno HT; Rider JR; Gunn CM
    JAMA Oncol; 2020 Jun; 6(6):815-816. PubMed ID: 32163096
    [No Abstract]   [Full Text] [Related]  

  • 107. Balancing uncertainty with patient autonomy in precision medicine.
    Pollard S; Sun S; Regier DA
    Nat Rev Genet; 2019 May; 20(5):251-252. PubMed ID: 30872766
    [No Abstract]   [Full Text] [Related]  

  • 108. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
    Knapp E
    J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
    [No Abstract]   [Full Text] [Related]  

  • 109. Birds of a Feather? Genetic Counseling, Genetic Testing, and Humanism.
    Resta R
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31548221
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Ethical considerations of genetic testing.
    Fleming DA
    J Clin Ethics; 2002; 13(4):316-23. PubMed ID: 12793324
    [No Abstract]   [Full Text] [Related]  

  • 111. Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.
    Freedman AN; Klabunde CN; Wiant K; Enewold L; Gray SW; Filipski KK; Keating NL; Leonard DGB; Lively T; McNeel TS; Minasian L; Potosky AL; Rivera DR; Schilsky RL; Schrag D; Simonds NI; Sineshaw HM; Struewing JP; Willis G; de Moor JS
    JCO Precis Oncol; 2018 Nov; 2():. PubMed ID: 35135159
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
    Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida.
    Vadaparampil ST; Scherr CL; Cragun D; Malo TL; Pal T
    Clin Genet; 2015 May; 87(5):473-7. PubMed ID: 24735105
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Physicians' attitudes about multiplex tumor genomic testing.
    Gray SW; Hicks-Courant K; Cronin A; Rollins BJ; Weeks JC
    J Clin Oncol; 2014 May; 32(13):1317-23. PubMed ID: 24663044
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
    Gray SW; Hicks-Courant K; Lathan CS; Garraway L; Park ER; Weeks JC
    J Oncol Pract; 2012 Nov; 8(6):329-35, 2 p following 335. PubMed ID: 23598841
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.